According to Zacks, “Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States. “
A number of other analysts also recently commented on the company. Barclays reiterated a “buy” rating and issued a $22.00 price objective on shares of Avantor in a research report on Thursday, July 18th. Janney Montgomery Scott reiterated a “buy” rating and issued a $18.70 price objective (down previously from $27.00) on shares of Avantor in a research report on Wednesday, June 26th. Finally, Cleveland Research assumed coverage on Avantor in a research report on Friday, August 2nd. They issued a “neutral” rating for the company. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and eighteen have issued a buy rating to the stock. Avantor currently has a consensus rating of “Buy” and a consensus price target of $20.81.
Avantor (NYSE:AVTR) last announced its earnings results on Tuesday, August 6th. The company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.03). The company had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.52 billion. The firm’s quarterly revenue was up 3.7% on a year-over-year basis. On average, research analysts predict that Avantor will post 0.57 EPS for the current fiscal year.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in AVTR. Coastal Investment Advisors Inc. acquired a new stake in shares of Avantor in the 2nd quarter valued at $69,000. JPMorgan Chase & Co. acquired a new stake in shares of Avantor in the 2nd quarter valued at $103,000. Russell Investments Group Ltd. acquired a new stake in shares of Avantor in the 2nd quarter valued at $113,000. FTB Advisors Inc. acquired a new stake in shares of Avantor in the 2nd quarter valued at $127,000. Finally, Tower Research Capital LLC TRC acquired a new stake in shares of Avantor in the 2nd quarter valued at $179,000. 73.48% of the stock is owned by institutional investors.
Avantor, Inc is a provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. It sells materials & consumables, equipment & instrumentation and services & specialty procurement. It operates in more than 30 countries and deliver an extensive portfolio of products and services.
Featured Article: What is diluted earnings per share (Diluted EPS)?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.